Fredrick Ogugua, MD, MPH

Interventional Cardiology Fellow at THH-Plano via @uiccardfellows, @HennepinHC , @publichealthUMN Alumnus #Cardiology

[Fredrick Ogugua, MD, MPH @fredrickeus]

In our paper published in @JACCJournals Zva was not associated with AVR, mortality, or their combined outcome in patients with coprevalent ESKD and AS. Thanks to mentors @shroffgr @PPibarot @UICcardfellows @TernacleJ

https://t.co/WIKyCJ1Yuw

[Fredrick Ogugua, MD, MPH @fredrickeus]

Our article details the multimodal evaluation and management of aortic stenosis in patients with kidney disease. https://t.co/J0saDz0BAd
@shroffgr @UICcardfellows

[Fredrick Ogugua, MD, MPH @fredrickeus]

Satisfying thrombectomy! #whyIC

[Fredrick Ogugua, MD, MPH @fredrickeus]

A lot of high yield information for management of peripheral artery disease at the NewYork Endovascular Summit! @UICcardfellows

[Philippe Pibarot @PPibarot]

Alain Cribier was a Giant of Cardiovascular Medicine and Innovation. He was THE pioneer of TAVI (first in man in 2002 @CHURouen). He was a great Gentleman. We will miss his vision, energy, inspiration and his smile. Rest in Peace Alain.

[Fredrick Ogugua, MD, MPH @fredrickeus]

@shroffgr @PPibarot @TernacleJ

[Fredrick Ogugua, MD, MPH @fredrickeus]

Our paper showed that among ESKD patients with AS, TTE parameters of flow states and AS severity differed depending on dialysis access types suggesting the need for astute and meticulous individualized attention to conventional TTE parameters used to calculate AS severity.

[Fredrick Ogugua, MD, MPH @fredrickeus]

Read below.

https://t.co/jnWTfcfe1a

[Dana Johnson MD MPH @rainylakedana]

Warming up on a cold morning with EP conference led by stellar fellow @DsGursukhman and @UICcardfellows. Dr. Avitall imparting a lifetime of wisdom.

@UIHealth #epeeps

[Fredrick Ogugua, MD, MPH @fredrickeus]

Our paper shows that systemic sclerosis has a distinct LGE phenotype and is independently associated with MACE. Read more at https://t.co/Wd3sEeHmyU @UICcardfellows #CMR

[Fredrick Ogugua, MD, MPH @fredrickeus]

Great time with great people!

[Sanjiv J. Shah, MD @HFpEF]

1/ #HFpEF treatment algorithm #tweetorial. This is the algorithm I currently use to treat HFpEF based on evidence we have thus far and my anecdotal experience treating patients over the past 16 years in the @NMCardioVasc HFpEF Clinic.

[UIC Cardio Fellows @UICcardfellows]

Excellent overview of #WhyCCT with imaging guru and PD @Ajauseon

[Medinbox @medinbox]

#ChinaStructuralWeek2022
#MITRACLIP at CHU Bordeaux with @Thomas Modine, @lionelleroux and @TernacleJ
#medinbox #interventionalcardiology #medtech

[UMN Medical School @umnmedschool]

“We believe our findings will help optimize the clinical care of patients with suspected #CardiacSarcoidosis, and consequently, lead to better outcomes.”

Read more ➡️: https://t.co/XV10XIeqle.
#Cardiology | #MRI

[UIC Cardio Fellows @UICcardfellows]

Also, proud of @fredrickeus for his recent publication in @JAMACardio for his research studying CMRI phenotypes and clinical outcomes in cardiac sarcoidosis! Way to go, Fredrick!
https://t.co/TnzkZW3Hb8

[UIC Cardio Fellows @UICcardfellows]

Next, another of our talented 1st years, @fredrickeus !
✨Residency: @HennepinHC
✨Hometown: Ukwulu, Nigeria
✨Career interests: Intervention, HF, Public Health, Tropical Med
✨Hobbies: Playing/watching 🏈, traveling
✨Why UIC: Abundant learning opportunities, world class faculty

[Fredrick Ogugua, MD, MPH @fredrickeus]

@UICcardfellows

[Fredrick Ogugua, MD, MPH @fredrickeus]

Officially a Cardiology Fellow at @UICcardfellows . Want to take a moment to thank @shroffgr (Chief of Cardiology, @HennepinHC ) for his mentorship and guidance. Couldn’t have done it without him!

[Gautam Shroff @shroffgr]

Congratulations for oral presentation at American Heart Association Scientific Sessions 2021 presented by Dr Fredrick Ogugua @fredrickeus from IM https://t.co/ZTvSORqaIK @HennepinHC @HennepinHC_GME @PPibarot #esrd #AHA21 #Dialysis @hcmcim @chitipamzungu